Zogenix Inc (USD)
ZGNX
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range17.23 | 18.08
52-Wk Range- | -
Last Close17.50
Mkt Cap (m)970.34
Dividend yield-
ISINUS98978L2043
Volume6,840,196.00
Exchange VenueNAS

Company Profile

Zogenix Inc is a pharmaceutical company engaged in commercializing and developing therapies that address clinical needs for people living with pain-related and CNS disorders that needs treatment alternatives to help return to normal daily functioning.

Key Information
Price/Earning-
Price/Book2.40
Price/Sales172.08
P/CF-
Rev Growth (3 year avg)-49.81
EPS Growth (3 year avg)-
Operating Margin % -4,736.38
Net Margin %-11,499.53
Return on Equity-109.27
Debt/Equity0.05

Documents

Prospectus
en 04/03/2020
Annual Report
en 31/12/2019

Please refer to the below issuer website for further documents.

https://www.zogenix.com

Financials

Income Statement
USD201420152016201720182019
Revenue (m)40.5327.1828.859.820.003.65
Operating Income (m)-99.18-49.73-62.45-94.24-139.88-172.78
Net Income (m)8.5926.14-69.71-126.82-123.91-419.50
Basic EPS0.481.22-2.81-4.65-3.27-9.74
Avg. Diluted Shares Outstanding (m)18.1321.4524.7927.3037.8843.08
Balance Sheet
USD201420152016201720182019
Current Assets (m)77.98184.60119.91304.70532.73287.24
Non Current Assets (m)124.86121.39111.59112.91115.60127.01
Total Assets (m)202.84305.99231.51417.61648.33414.25
Current Liabilities (m)44.2430.0820.3120.9858.3895.39
Total Liabilities (m)------
Total Equity (m)55.28182.76120.76301.52522.80245.06
Cash Flows
USD201420152016201720182019
Operating Cash Flows (m)-80.82-64.60-72.88-75.87-111.66-111.52
Capital Expenditure (m)-0.12-0.31-0.10-0.08-1.02-9.49
Figures are quoted in USD unless stated otherwise
-
No change
$
17.50
Last Price